We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.
Xenon is advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.Read More
Xenon Provides Key Regulatory Updates on XEN007 and XEN1101
January 28, 2019
Xenon Outlines 2019 Key Milestones
January 6, 2019